A Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Xyrem® (sodium oxybate) in Subjects with Fibromyalgia

Update Il y a 4 ans
Reference: EUCTR2006-006075-20

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To evaluate the safety and efficacy of Xyrem (sodium oxybate) oral solution at 4.5 g/night and 6 g/night compared to placebo for the treatment of fibromyalgia in a randomized, double-blind, placebo controlled, parallel-group trial.


Inclusion criteria

  • Fibromyalgia